Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

BioVec obtains United States patent.


BioVec, LLC (Logical Link Control) See "LANs" under data link protocol.

LLC - Logical Link Control
 (Chicago, IL) has patented methods and compositions for treatment of cardiovascular and peripheral vascular diseases using ex vivo ex vivo /ex vi·vo/ (eks´ ve´vo) outside the living body; denoting removal of an organ (e.g., the kidney) for reparative surgery, after which it is returned to the original site.  and in vivo gene delivery technologies. One aspect of the present invention relates to a method for treating a vascular disease by introducing a DNA sequence encoding a TM protein or its variant into a segment of a blood vessel ex vivo using a gutless adenovirus adenovirus

Any of a group of spheroidal viruses, made up of DNA wrapped in a protein coat, that cause sore throat and fever in humans, hepatitis in dogs, and several diseases in fowl, mice, cattle, pigs, and monkeys.
 vector. Another aspect of the present invention is to provide a gutless adenovirus vector carrying a transgene transgene

a gene that has been incorporated into the genome of another organism.
, such as a gene encoding TM protein or its variant. (US 7,481,998)
COPYRIGHT 2008 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:BIOTECH Patent News
Date:Dec 1, 2008
Words:97
Previous Article:Gladstone Institutes obtains United States patent.
Next Article:Bion Announces Approval of New Australian Patent for Low Oxygen Organic Waste Bioconversion.
Topics:

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles